Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Follow-Up Questions
¿Quién es el CEO de Uni-Bio Science Group Ltd?
Mr. Zhi Gang Zhao es el Chief Executive Officer de Uni-Bio Science Group Ltd, se unió a la empresa desde 2014.
¿Qué tal es el rendimiento del precio de la acción UNBSF?
El precio actual de UNBSF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Uni-Bio Science Group Ltd?
Uni-Bio Science Group Ltd pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Uni-Bio Science Group Ltd?
La capitalización bursátil actual de Uni-Bio Science Group Ltd es $0
